Opportunities in China

At China Focus@BIO Philadelphia, we are going to bring together 100+ Chinese executives from pharma, medical device companies and investment institutions. Some attendees are seeking assets and strategic partners in following categories:

  • CNS and oncology.
    • Requirements: New formulation or cell and gene therapy. Clinical stage.
  • Oncology and autoimmune.
    • Requirements: Innovative drugs–Novel antibody, RNAi or oncolytic virus.

Contact us if you are interested in exploring potential possibilities in China market.

More Opportunities Available

Our Partnering System is open! Register now and start requesting 1-1 meetings with your best-fit partners to make the most of your trip in Philadelphia.

Register Now

If you don’t know well about our event, we’re hosting two webinars to answer common questions. We can help you navigate this event and figure out whether it fits your strategy and budget. Welcome to join us and discuss immediate investment or collaboration opportunities in China market.

  • Webinar 1
    • Time: May 13, 2019 4:00 PM Eastern Time (US and Canada)
    • Register in advance for this meeting:
      https://zoom.us/meeting/register/6c4011470fe38848d746f627e8486654 
  • Webinar 2
    • Time: May 15, 2019 11:30 AM Eastern Time (US and Canada)
    • Register in advance for this meeting:
      https://zoom.us/meeting/register/b35b7197228564c434538d7d4481ef37 

Participating Chinese Companies Spotlight

Fosun Pharma regards innovation, research and development as the core driving factor of development and established innovative chemical drugs platform, biologics platform, high-value generic drugs platform and cell-therapy platform. Currently, Fosun Pharma continues to focus on therapeutic areas including oncology, cardiovascular system, central nervous system, blood system, metabolism and alimentary system and anti-infection.
Kelun Pharmaceutical is committed to R&D for small-molecule NCEs and biological NBEs, biosimilars, generic drugs, and new drug delivery systems (NDDS) in oncology, diabetes, hepatitis, cardiovascular and other major disease areas
WuXi Biologics offers multinational pharmaceutical and biotechnological companies in the world end-to-end solutions empowering anyone and any company to discover, develop and manufacture biologics from concept to commercial manufacturing.
I-Mab is an innovative biopharmaceutical company with an exclusive focus on biologics with first-in-class and best-in-class potential in the therapeutic areas of immuno-oncology and immuno-inflammation. The major pipeline assets take three different molecular formats: (1) monoclonal antibody, (2) antibody-cytokine fusion molecule (immuno-cytokine), and (3) bi-specific antibody
Luye Boston R&D is commited to leading the evolution of these treatments by pursuing innovative research technologies driven by our deep understanding of pathways, targets, and novel drug delivery systems of oncologoical, neurological, and metabolic treatments.
Reistone Biopharma Company Limited is a clinical stage biopharmaceutical company focused on developing novel medicines for life threatening autoimmune diseases.
Huadong Medicine Co.,Ltd specializes in the production and sales of antibiotic, Chinese patent medicine, synthetic drug, genetic engineering drugs, as well as wholesale business of Chinese and western medicine, Chinese herbal medicines, medical apparatus and instruments.
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform.
Morningside Group makes private equity and venture capital investments. The group is managed by investment professionals who are entrepreneurial, have deep industry knowledge and are effective in the local environment in which they operate.

Click here to download a partial list of attending companies.

Register to Schedule 1-1 Meeting with Other Attendees

Innovation Competition

Upcoming Preliminaries: 

  • June 2, Philadelphia (Online Application Deadline: May 22)
    • 1-to-1 partnering opportunities with potential Chinese investors.
    • Exhibition booth for your company at China Focus@BIO Philadelphia with a surprise discount.
    • Media coverage and promotion on our English and Chinese platforms.
    • Opportunity for a 5-day sponsored business development trip in China to meet 100+ investors and corporate executives.
Submit Application Now

Click here to learn more about preliminary schedule and featured prizes.

Partner Event

For China Focus attendees, we provide special discount code of BIO International Convention in Philadelphia on June 3-6.
Contact us to get $400 off for Convention Access and above.